DOSHI JITENDRA N 4
4 · CARACO PHARMACEUTICAL LABORATORIES LTD · Filed Jul 29, 2010
Insider Transaction Report
Form 4
DOSHI JITENDRA N
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2010-07-27$6.04/sh−10,246$61,886→ 38,254 total - Sale
Common Stock
2010-07-27$6.06/sh−600$3,636→ 37,254 total - Sale
Common Stock
2010-07-28$6.04/sh−5,700$34,428→ 30,700 total - Sale
Common Stock
2010-07-27$6.07/sh−854$5,184→ 36,400 total - Sale
Common Stock
2010-07-29$6.05/sh−300$1,815→ 29,400 total - Sale
Common Stock
2010-07-29$6.06/sh−1,200$7,272→ 28,200 total - Sale
Common Stock
2010-07-29$6.10/sh−100$610→ 27,400 total - Sale
Common Stock
2010-07-27$6.05/sh−400$2,420→ 37,854 total - Sale
Common Stock
2010-07-29$6.04/sh−1,000$6,040→ 29,700 total - Sale
Common Stock
2010-07-29$6.07/sh−400$2,428→ 27,800 total - Sale
Common Stock
2010-07-29$6.08/sh−300$1,824→ 27,500 total
Holdings
- 26,500(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]On June 11, 2010, the reporting person entered into a Rule 10b-5 trading plan to sell up to 45,000 shares of common stock for estate and tax planning purposes. The reported sales were effected pursuant to such Rule 10b5-1 trading plan.